Poseida Therapeutics, Inc. (PSTX)

Poseida Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	297	321	456	426	678	-
Market Cap Growth	15.50%	-29.47%	7.02%	-37.23%	-	-
Enterprise Value	183	195	262	281	428	-96
PE Ratio	-	-2.60	-7.12	-3.41	-5.23	-
PS Ratio	3.60	4.97	3.49	13.63	-	-
PB Ratio	3.51	3.10	2.43	2.73	2.59	-
P/FCF Ratio	-4.29	-3.37	-14.85	-4.05	-5.21	-
P/OCF Ratio	-4.44	-3.49	-17.02	-4.15	-5.98	-
EV/Sales Ratio	2.21	3.01	2.01	8.98	-	-
EV/EBITDA Ratio	-2.06	-1.78	-5.04	-2.40	-3.46	1.18
EV/EBIT Ratio	-1.94	-1.70	-4.59	-2.31	-3.39	1.16
EV/FCF Ratio	-2.70	-2.04	-8.53	-2.67	-3.29	1.38
Debt / Equity Ratio	1.00	0.82	0.47	0.39	0.23	-0.19
Debt / EBITDA Ratio	-0.90	-0.78	-1.71	-0.52	-0.48	-0.36
Debt / FCF Ratio	-1.18	-0.90	-2.89	-0.58	-0.46	-0.42
Quick Ratio	2.49	3.10	5.41	4.76	10.30	5.73
Current Ratio	2.56	3.18	5.54	4.93	10.46	5.82
Asset Turnover	0.30	0.22	0.44	0.11	0	0
Interest Coverage	-11.22	-13.22	-8.96	-36.22	-36.02	-23.35
Return on Equity (ROE)	-97.40%	-94.90%	-44.60%	-69.40%	-230.80%	76.50%
Return on Assets (ROA)	-38.90%	-42.20%	-21.60%	-43.00%	-50.10%	-90.10%
Return on Capital (ROIC)	-67.73%	-68.48%	-21.69%	-65.04%	-39.39%	71.06%
Earnings Yield	-36.69%	-38.42%	-14.05%	-29.36%	-19.14%	-
FCF Yield	-24.17%	-29.64%	-6.74%	-24.70%	-19.20%	-
Buyback Yield / Dilution	-11.31%	-25.34%	-15.61%	-72.89%	-185.27%	-3.57%
Total Shareholder Return	-11.31%	-25.34%	-15.61%	-72.89%	-185.27%	-3.57%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).